Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia.
AIMS:Glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP4) inhibitors improve glucose tolerance by still incompletely understood mechanisms. Each class of antihyperglycemic drugs has also been proposed to increase pancreatitis risk. Here, we compare systematically the e...
Main Authors: | Angeles Mondragon, Daniel Davidsson, Styliana Kyriakoudi, Annika Bertling, Rosa Gomes-Faria, Patrizia Cohen, Stephen Rothery, Pauline Chabosseau, Guy A Rutter, Gabriela da Silva Xavier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4132080?pdf=render |
Similar Items
-
The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
by: Suvanjaa Sivalingam, et al.
Published: (2021-05-01) -
Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand
by: Deerochanawong C, et al.
Published: (2019-07-01) -
The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
by: Takamasa Ohki, et al.
Published: (2012-01-01) -
Exendin-4 and Liraglutide Attenuate Glucose Toxicity-Induced Cardiac Injury through mTOR/ULK1-Dependent Autophagy
by: Wei Yu, et al.
Published: (2018-01-01) -
Importance of Both Imprinted Genes and Functional Heterogeneity in Pancreatic Beta Cells: Is There a Link?
by: Pauline Chabosseau, et al.
Published: (2021-01-01)